3-54918837-G-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_020678.4(LRTM1):​c.660C>A​(p.Asp220Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 31)

Consequence

LRTM1
NM_020678.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.04
Variant links:
Genes affected
LRTM1 (HGNC:25023): (leucine rich repeats and transmembrane domains 1) Predicted to enable Roundabout binding activity and heparin binding activity. Predicted to be involved in axon guidance and negative chemotaxis. Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
CACNA2D3 (HGNC:15460): (calcium voltage-gated channel auxiliary subunit alpha2delta 3) This gene encodes a member of the alpha-2/delta subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. Various versions of each of these subunits exist, either expressed from similar genes or the result of alternative splicing. Research on a highly similar protein in rabbit suggests the protein described in this record is cleaved into alpha-2 and delta subunits. Alternate transcriptional splice variants of this gene have been observed but have not been thoroughly characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17418468).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LRTM1NM_020678.4 linkc.660C>A p.Asp220Glu missense_variant 3/3 ENST00000273286.6 NP_065729.1 Q9HBL6-1
CACNA2D3NM_018398.3 linkc.2449+18969G>T intron_variant ENST00000474759.6 NP_060868.2 Q8IZS8-1
LRTM1NM_001304389.2 linkc.432C>A p.Asp144Glu missense_variant 3/3 NP_001291318.1 Q9HBL6-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LRTM1ENST00000273286.6 linkc.660C>A p.Asp220Glu missense_variant 3/31 NM_020678.4 ENSP00000273286.5 Q9HBL6-1
CACNA2D3ENST00000474759.6 linkc.2449+18969G>T intron_variant 1 NM_018398.3 ENSP00000419101.1 Q8IZS8-1

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
31

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 09, 2024The c.660C>A (p.D220E) alteration is located in exon 3 (coding exon 3) of the LRTM1 gene. This alteration results from a C to A substitution at nucleotide position 660, causing the aspartic acid (D) at amino acid position 220 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0072
T;.
Eigen
Benign
-0.34
Eigen_PC
Benign
-0.19
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.56
T;T
M_CAP
Benign
0.0050
T
MetaRNN
Benign
0.17
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;.
PrimateAI
Benign
0.41
T
PROVEAN
Benign
-0.97
N;N
REVEL
Benign
0.044
Sift
Benign
0.083
T;D
Sift4G
Benign
0.20
T;T
Polyphen
0.027
B;.
Vest4
0.10
MutPred
0.29
Loss of ubiquitination at K217 (P = 0.1055);.;
MVP
0.57
MPC
0.019
ClinPred
0.41
T
GERP RS
3.1
Varity_R
0.037
gMVP
0.32

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr3-54952864; API